Actively Recruiting
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Led by Peking Union Medical College Hospital · Updated on 2026-03-11
30
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.
CONDITIONS
Official Title
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 85 years old
- Tumor patients able to undergo surgery or biopsy to obtain pathological diagnosis
- Ability to understand and sign informed consent forms
- Expected survival period exceeding 6 months and able to receive follow-up
- Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc
You will not qualify if you...
- Pregnant or lactating women
- Patients allergic to research drug ingredients
- Patients with severe liver and kidney dysfunction (blood creatinine levels exceeding 159 bc mol/L)
- Patients participating in other clinical trials that interfere with this study
- Patients with severe illness who cannot cooperate with the examination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, China
Actively Recruiting
Research Team
Z
Zhu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here